In a Sep 16 letter to NABP CEO Al Carter, FDA states that DTE products “can put patients at harm” and that “therapies containing DTE are biological products subject to licensure under Section 351(i) of the PHS Act.” read more →
One result of last week’s Compounders on Capitol Hill visits has been the creation of a joint congressional letter to FDA’s Center for Veterinary Medicine raising concerns about the great ambiguity in GFI 256 on animal compounding read more →
One result of last week’s Compounders on Capitol Hill has been the creation of a joint congressional letter to FDA’s Center for Veterinary Medicine raising concerns about the great ambiguity in GFI 256 on animal compounding, read more →
In what, honestly, isn’t all that surprising, Covid-19 cases are surging across the country just a couple of weeks after states began reopening.
Per Reuters: “Alabama reported a record number of new cases for the fourth day in a row on Sunday. Alaska, Arizona, Arkansas, California, Florida, North Carolina, Oklahoma and South Carolina all had record numbers of new cases in the past three days, according to a Reuters tally.” (https://fllw.me/3fq2aUD)
What *is* surprising: “Per capita, Arizona’s infection rate is now more than three times higher than New York state.” (https://fllw.me/2YEhJkL)
And this probably counts as irony: Total cases in the US are going *down* … because cases in the New York area are going down. (https://fllw.me/3fs1nCQ)
Patients afraid to shake? They’re not alone. Read a survey (full of charts!) of 511 infectious disease specialists to see when they “Expect to Fly, Hug and Do 18 Other Everyday Activities Again”: https://nyti.ms/2AfC7R7 (Spoiler: The handshake is dead.)